1. Home
  2. KURA vs MITK Comparison

KURA vs MITK Comparison

Compare KURA & MITK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kura Oncology Inc.

KURA

Kura Oncology Inc.

HOLD

Current Price

$10.40

Market Cap

841.6M

Sector

Health Care

ML Signal

HOLD

Logo Mitek Systems Inc.

MITK

Mitek Systems Inc.

HOLD

Current Price

$17.02

Market Cap

723.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
KURA
MITK
Founded
2014
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Computer peripheral equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
841.6M
723.9M
IPO Year
2015
1995

Fundamental Metrics

Financial Performance
Metric
KURA
MITK
Price
$10.40
$17.02
Analyst Decision
Buy
Strong Buy
Analyst Count
11
1
Target Price
$25.56
$15.00
AVG Volume (30 Days)
1.4M
799.2K
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
171.43
EPS
N/A
0.25
Revenue
$67,482,000.00
$45,390,000.00
Revenue This Year
$28.28
$9.55
Revenue Next Year
$106.37
$8.07
P/E Ratio
N/A
$68.04
Revenue Growth
25.24
N/A
52 Week Low
$5.45
$8.53
52 Week High
$12.49
$21.05

Technical Indicators

Market Signals
Indicator
KURA
MITK
Relative Strength Index (RSI) 45.63 43.51
Support Level $8.53 $13.15
Resistance Level $10.97 $17.97
Average True Range (ATR) 0.47 0.91
MACD -0.17 -0.41
Stochastic Oscillator 10.29 32.16

Price Performance

Historical Comparison
KURA
MITK

About KURA Kura Oncology Inc.

Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.

About MITK Mitek Systems Inc.

Mitek Systems Inc is engaged in the development, sale, and service of proprietary software solutions related to mobile imaging. The firm is a software development company with expertise in artificial intelligence, and machine learning. It serves more than 7,900 financial services organizations, financial technology (fintech) brands, telecommunications companies, and marketplace brands across the globe. The company's Mobile Deposit solution is used by consumers for mobile check deposits. The company's Mobile Verify verifies a user's identity online, enabling organizations to build safer digital communities, whereas CheckReader enables financial institutions to automatically extract data from a check image received across any deposit channel - branch, ATM, RDC, and mobile.

Share on Social Networks: